Orphina Biotechnology
PrivateCompany Overview
Orphina Biotechnology is a biotechnology company that develops gene therapies for preserving and prolonging muscle health, with an initial focus on GNE myopathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
gene therapyGNE MyopathyGNEMrare diseasenon-viral gene therapymuscle-wasting diseaseorphan drugbiotech startupdrug discoveryclinical developmenttherapeutic pipelineskeletal muscle therapybiotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orphina Biotechnology Comparables
Compare Orphina Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genosera Inc. | 86% | |
| Myosana Therapeutics | 84% | |
| Spot Biosystems | 82% | |
Orphina Biotechnology Funding Rounds
Historical fundraising activity
Orphina Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orphina Biotechnology's valuation, stock price, and market status.
Firmographic Details
HeadquartersCalabasas, California
Employee Range2
Year Founded2020
Last Funding—
See something wrong or outdated?